Vaxart to Speak at World Vaccine Congress Washington 2024 on April 3

Mark Herr, Vaxart’s Founder and Chief Scientific Officer, announced that the company will be presenting at the World Vaccine Congress Washington 2024 in Washington, D.C. on April 3, 2024. This is a recurring appearance for the company at the annual event in Washington, D.C.

During his presentation, Dr. Herr will discuss the topic of “Moving the needle: Blocking transmission and boosting existing vaccines through oral tablet vaccination.” The presentation is scheduled for Wednesday, April 3, 2024 at 3:10 p.m. Eastern Time in Room 207A.

Vaxart is a clinical-stage biotechnology company that specializes in developing oral recombinant vaccines using its proprietary delivery platform. These vaccines are designed to be administered via pills, allowing for easy storage and shipping without refrigeration while eliminating the risk of needle-stick injuries. The company believes that its pill vaccine delivery platform is well-suited for delivering a range of vaccines including oral versions of existing vaccines and new indications.

Currently, Vaxart’s development programs include pill vaccines for protection against coronavirus, norovirus and influenza as well as a therapeutic vaccine for human papillomavirus (HPV), which is their first immune-oncology indication. The company has also filed various patent applications domestically and internationally to cover its proprietary technology and creations related to oral vaccination using adenovirus and TLR3 agonists.

By Aiden Johnson

As a content writer at newspoip.com, I have a passion for crafting engaging and informative articles that captivate readers. With a keen eye for detail and a knack for storytelling, I strive to deliver content that not only informs but also entertains. My goal is to create compelling narratives that resonate with our audience and keep them coming back for more. Whether I'm delving into the latest news topics or exploring in-depth features, I am dedicated to producing high-quality content that informs, inspires, and sparks curiosity.

Leave a Reply